BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 25747892)

  • 1. Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system.
    Lo JC; Rivkees SA; Chandra M; Gonzalez JR; Korelitz JJ; Kuzniewicz MW
    Thyroid; 2015 Jun; 25(6):698-705. PubMed ID: 25747892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States.
    Korelitz JJ; McNally DL; Masters MN; Li SX; Xu Y; Rivkees SA
    Thyroid; 2013 Jun; 23(6):758-65. PubMed ID: 23194469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
    Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
    BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
    Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
    J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital thyrotoxicosis in premature infants.
    Smith C; Thomsett M; Choong C; Rodda C; McIntyre HD; Cotterill AM
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):371-6. PubMed ID: 11298090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study.
    Andersen SL; Lönn S; Vestergaard P; Törring O
    Eur J Endocrinol; 2017 Oct; 177(4):369-378. PubMed ID: 28780518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of and Risk Factors for Neonatal Hypothyroidism Among Women with Graves' Disease Treated with Antithyroid Drugs Until Delivery.
    Yoshihara A; Noh JY; Inoue K; Watanabe N; Fukushita M; Matsumoto M; Suzuki N; Suzuki A; Kinoshita A; Yoshimura R; Aida A; Imai H; Hiruma S; Sugino K; Ito K
    Thyroid; 2023 Mar; 33(3):373-379. PubMed ID: 36680759
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
    Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
    Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
    Yang J; Li LF; Xu Q; Zhang J; Weng WW; Zhu YJ; Dong MJ
    Thyroid; 2015 Mar; 25(3):278-83. PubMed ID: 25384184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk?
    Laurberg P; Andersen SL
    Eur J Endocrinol; 2014 Jul; 171(1):R13-20. PubMed ID: 24662319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
    Agrawal M; Lewis S; Premawardhana L; Dayan CM; Taylor PN; Okosieme OE
    Clin Endocrinol (Oxf); 2022 Jun; 96(6):857-868. PubMed ID: 34845757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal Thyroid Function, Use of Antithyroid Drugs in Early Pregnancy, and Birth Defects.
    Andersen SL; Knøsgaard L; Olsen J; Vestergaard P; Andersen S
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6040-6048. PubMed ID: 31408173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis.
    Song R; Lin H; Chen Y; Zhang X; Feng W
    PLoS One; 2017; 12(7):e0180108. PubMed ID: 28671971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
    Hackmon R; Blichowski M; Koren G
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicological considerations for antithyroid drugs in children.
    Karras S; Tzotzas T; Krassas GE
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):399-410. PubMed ID: 21323607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity and cutaneous reactions after antithyroid drug administration.
    Otsuka F; Noh JY; Chino T; Shimizu T; Mukasa K; Ito K; Ito K; Taniyama M
    Clin Endocrinol (Oxf); 2012 Aug; 77(2):310-5. PubMed ID: 22332800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data.
    Karras S; Tzotzas T; Kaltsas T; Krassas GE
    Pediatr Endocrinol Rev; 2010 Sep; 8(1):25-33. PubMed ID: 21037541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hyperthyroidism during pregnancy and lactation.
    Azizi F; Amouzegar A
    Eur J Endocrinol; 2011 Jun; 164(6):871-6. PubMed ID: 21389085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.